首页|期刊导航|辽宁中医药大学学报|基于PI3K/Akt通路探讨益气化瘀方延缓糖尿病肾脏病的作用机制

基于PI3K/Akt通路探讨益气化瘀方延缓糖尿病肾脏病的作用机制OA

Mechanism of Yiqi Huayu Decoction(益气化瘀方)in Delaying Diabetic Kidney Disease Based on PI3K/Akt Signaling Pathway

中文摘要英文摘要

目的 探讨益气化瘀方通过磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)通路延缓糖尿病肾脏病(DKD)的作用机制.方法 将36只SPF级雄性SD大鼠随机分为空白组、模型组、达格列净组和益气化瘀方低、中、高剂量组,每组6只,采用高糖高脂饲料喂养并腹腔注射链脲佐菌素(STZ)诱导构建DKD大鼠模型.从给药开始,每2周检测大鼠尾静脉空腹血糖(FBG),给药8周后采集大鼠血、尿及肾脏组织标本,检测大鼠24 h尿蛋白定量(24 h UTP)、血肌酐(Scr)、血清尿素氮(BUN)、总胆固醇(TC)、甘油三酯(TG);苏木素-伊红(HE)染色及马松(Masson)染色观察大鼠肾脏组织病理变化;酶联免疫吸附测定(ELISA)检测血清白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)的表达;免疫组织化学法(IHC)测定大鼠肾脏组织p-PI3K及p-Akt蛋白的表达.结果 经药物干预后,益气化瘀方高剂量组大鼠FBG、24 h UTP、Scr、BUN、TC、TG水平较模型组显著下降(P<0.01).HE和Masson染色结果显示,与空白组相比,模型组大鼠出现肾小球体积增大、肾小管细胞肿胀、空泡变性、胶原沉积明显等病理改变;与模型组相比,益气化瘀方显著改善DKD大鼠肾脏组织的病理损伤,使胶原沉积减少.ELISA结果显示,与模型组相比,益气化瘀方中、高剂量组IL-6、TNF-α表达水平下降(P<0.01).免疫组化结果显示,与空白组相比,模型组p-PI3K及p-Akt蛋白表达水平升高(P<0.01);与模型组相比,益气化瘀方中、高剂量组p-PI3K及p-Akt蛋白表达水平明显下降(P<0.01).结论 益气化瘀方能调节DKD大鼠糖脂代谢紊乱,改善肾功能,减少蛋白尿产生,减轻炎症反应,延缓DKD大鼠肾组织损伤,其机制可能与抑制PI3K/Akt通路活化相关.

Objective To explore the role and mechanism of Yiqi Huayu Decoction(益气化瘀方)in delaying diabetic kidney disease via the PI3K/Akt pathway.Methods Thirty-six male SD rats,SPF-grade,were randomly divided into six groups:blank group,model group,dapagliflozin group,and Yiqi Huayu Decoction low,medium and high dose groups,with 6 rats in each group.The model group was constructed by feeding with high sugar and fat and inducing intraperitoneal injection of streptozotocin(STZ).Starting from the beginning of administration,fasting blood glucose(FBG)was measured in rats every two weeks via tail vein sampling.After 8 weeks of administration,blood,urine,and tissue samples were collected from rats to detect 24 h urine protein quantification(24 h UTP),serum creatinine(Scr),serum urea nitrogen(BUN),total cholesterol(TC),triglycerides(TG);Hematoxylin-eosin(HE)and Masson staining to observe the histopathological changes and collagen deposition in rat kidney;Enzyme-linked immunosorbent assay(ELISA)was performed to detect the levels of the interleukin-6(IL-6),and tumor necrosis factor-α(TNF-α);Expression of protein of p-PI3K and p-Akt in rat kidney tissues were measured by immunohistochemistry(IHC).Results After drug intervention,the expressions of FBG,24 h UTP,Scr,BUN,TC,TG in the high-dose Yiqi Huayu Decoction group were significantly lower than those in model group(P<0.01).The results from HE and Masson staining showed that,compared with the blank group,rats in the model group exhibited pathological alterations including enlarged glomerular volume,swollen tubular cells,vacuolar degeneration,and marked collagen deposition.Compared with the model group,Yiqi Huayu Decoction significantly ameliorated pathological damage and reduced collagen deposition in renal tissues of DKD rats.ELISA results demonstrated that,compared with the model group,the expressions of IL-6 and TNF-α in the medium and high dose Yiqi Huayu Decoction groups were decreased(P<0.01).Immunohistochemistry results showed that compared with the blank group,the expression levels of p-PI3K and p-Akt in the model group were increased(P<0.01).Compared with the model group,the expression levels of p-PI3K and p-Akt in the medium and high dose Yiqi Huayu Decoction groups were significantly decreased(P<0.01).Conclusion Yiqi Huayu Decoction can regulate glucose and lipid metabolism disorders,improve renal function,reduce proteinuria,alleviate inflammatory responses,and delay renal tissue injury in DKD rats.Its mechanism may be related to the inhibition of PI3K/Akt pathway activation.

周寒;钟小美;张琦;李伊凌;吴学敏

广州中医药大学深圳医院(福田),广东 深圳 518000||广州中医药大学第六临床医学院,广东 深圳 518000广州中医药大学深圳医院(福田),广东 深圳 518000||广州中医药大学第六临床医学院,广东 深圳 518000广州中医药大学深圳医院(福田),广东 深圳 518000广州中医药大学深圳医院(福田),广东 深圳 518000||广州中医药大学第六临床医学院,广东 深圳 518000广州中医药大学深圳医院(福田),广东 深圳 518000

医药卫生

益气化瘀方糖尿病肾脏病PI3K/Akt通路中医药糖脂代谢

Yiqi Huayu Decoction(益气化瘀方)diabetic kidney diseasePI3K/Akt pathwaytraditional Chinese medicineglucose and lipid metabolism

《辽宁中医药大学学报》 2026 (8)

24-29,6

国家自然科学基金项目(82374380)深圳市"医疗卫生三名工程"项目(SZZYSM202202010)深圳市福田区卫生公益性科研项目(FTWS2021050)

10.13194/j.issn.1673-842X.2026.08.005

评论